Award
National Institute of Allergy and Infectious Diseases 11352556
Bloodstream infection detection directly on whole blood
Recipient
Scanogen, Inc., Baltimore, MD, United States
Award Amount
$1,000,000.00
Ceiling
$1,000,000.00
Awarded
June 30, 2026
Identifier
11352556
This award funds the development and validation of an automated molecular diagnostic platform to rapidly detect yeast bloodstream infections directly from whole blood, significantly reducing diagnosis time and improving patient outcomes.
Description
Development of a fully automated molecular platform for the diagnosis of bloodstream infections directly from whole blood without the need for blood culture. The assay identifies a panel of relevant yeasts and broadly detects Candida species with a turnaround time of 1.2 hours, addressing the urgent need for rapid identification of yeast pathogens in patients suspected of sepsis.